Identification of 'super-responders' to cardiac resynchronization therapy: The importance of symptom duration and left ventricular geometry

Europace

Volumn 11, Issue 3, 2009, Pages 343-349

  António, Natália ^a   Teixeira, Rogério ^a   Coelho, Lourenço ^a   Lourenço, Carolina ^a   Monteiro, Pedro ^a   Ventura, Miguel ^a   Cristóvão, João ^a   Elvas, Luís ^a   Gonçalves, Lino ^a   Providência, Luís A ^a  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

Author keywords

Echocardiography; Heart failure; Resynchronization therapy; Super responders

Indexed keywords

ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; DISEASE DURATION; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE VOLUME; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; STATISTICAL ANALYSIS; TREATMENT RESPONSE;

CARDIAC PACING, ARTIFICIAL; CARDIOMYOPATHY, DILATED; COMORBIDITY; FEMALE; HUMANS; MALE; MIDDLE AGED; PORTUGAL; PROGNOSIS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 61649095892     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eup038     Document Type: Article

References (13)

1. Vardas PE, Auricchio A, Blanc J-J, Daubert J-C, Drexler H, Ector H et al. Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in Collaboration with the European Heart Rhythm Association. Eur Heart J 2007;28:2256-95.
2. Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 2005;26:1115-540.
3. Duncan AM, Lim E, Clague J, Gibson DG, Henein MY. Comparison of segmental and global markers of dyssynchrony in predicting clinical response to cardiac resynchronization. Eur Heart J 2006;27:2426-32.
4. Yu C-M, Gorcsan Iii J, Bleeker GB, Zhang Q, Schalij MJ, Suffoletto MS et al. Usefulness of tissue Doppler velocity and strain dyssynchrony for predicting left ventricular reverse remodeling response after cardiac resynchronization therapy. Am J Cardiol 2007;100:1263-70.
5. Yu C-M, Bleeker GB, Fung JW-H, Schalij MJ, Zhang Q, van der Wall EE et al. Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy. Circulation 2005;112:1580-6.
6. Castellant P, Fatemi M, Bertault-Valls V, Etienne Y, Blanc J-J. Cardiac resynchronization therapy: 'nonresponders' and 'hyperresponders'. Heart Rhythm 2008;5:193-7.
7. Schiller N, Shah P, Crawford M, DeMaria A, Devereux R, Feigenbaum H et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358-67.
8. Schiller N. Two-dimensional echocardiographic determination of left ventricular volume, systolic function, and mass. Summary and Discussion of the 1989 Recommendations of the American Society of Echocardiography. Circulation 1991;84:280-7.
9. Hung J, Papakostas L, Tahta SA, Hardy BG, Bollen BA, Duran CM et al. Mechanism of recurrent ischemic mitral regurgitation after annuloplasty: continued LV remodeling as a moving target. Circulation 2004;110:II85-90.
10. Gasparini M, Regoli F, Ceriotti C, Galimberti P, Bragato R, De Vita S et al. Remission of left ventricular systolic dysfunction and of heart failure symptoms after cardiac resynchronization therapy: temporal pattern and clinical predictors. Am Heart J 2008;155:507-14.
11. Gasparini M, Auricchio A, Regoli F, Fantoni C, Kawabata M, Galimberti P et al. Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation. J Am Coll Cardiol 2006;48:734-43.
12. Landolina M, Lunati M, Gasparini M, Santini M, Padeletti L, Achilli A et al. Comparison of the effects of cardiac resynchronization therapy in patients with class II versus class III and IV heart failure (from the InSync/InSync ICD Italian Registry). Am J Cardiol 2007;100:1007- 12.
13. Yu C-M, Chan Y-S, Zhang Q, Yip GWK, Chan C-K, Kum LCC et al. Benefits of cardiac resynchronization therapy for heart failure patients with narrow QRS complexes and coexisting systolic asynchrony by echocardiography. J Am Coll Cardiol 2006;48:2251-7.